Accrued Expenses

6 Months Ended

Jun. 30, 2011

Accrued Expenses [Abstract]

ACCRUED EXPENSES

NOTE 4: ACCRUED EXPENSES

     The components of accrued expenses are as follows (in thousands):

	June 30,		December 31,
	2011		2010
Accrued product returns	$	13,990	$	15,025
Accrued rebates		3,043		3,034
Accrued price adjustments and chargebacks		15,309		21,520
Accrued compensation and benefits		2,275		2,760
Accrued royalties		3,030		3,303
Accrued expenses, other		946		957
Total accrued expenses	$	38,593	$	46,599

     The Company has ceased manufacturing and distribution of ALLERX and HYOMAX. As of June 30, 2011 and December 31, 2010, the Company had $32.4 million and $57.2 million, respectively, of deferred revenue related to sales of its remaining inventory of these products for which future returns could not be reasonably estimated at the time of sale. Deferred revenue was recorded net of estimated allowances for rebates, price adjustments, chargebacks, and prompt payment and other discounts. Estimated allowances were recorded as accrued expenses as of December 31, 2010.